Latest Breaking News On - Precise tumor - Page 1 : comparemela.com

Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024

SALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven

Salt lake cityUnited statesGeorge daneker jrMatt scaloBracanalysis cdxHollyj pedersonGlenn farrellBreast servicesOncology solutionsMemorial sloan kettering cancer centerCollaborative research registryGenetics incNational cancer center hospitalExchange commissionUniversity of texas md anderson cancer centerA myriad collaborative research registry study

Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting

Molecular Residual Disease study and multiple RiskScore studies among seven new datasets to be shared by Myriad and Collaborators SALT LAKE CITY, May 23, 2024 Myriad Genetics, Inc., , a leader.

United statesSalt lake cityMatt scaloGeorge daneker jrBracanalysis cdxHollyj pedersonGlenn farrellExchange commissionA myriad collaborative research registry studyGenetics incBreast servicesUniversity of texas md anderson cancer centerCollaborative research registryNational cancer center hospitalMemorial sloan kettering cancer centerOncology solutions

Myriad Genetics Showcases New Research and Product

Myriad Genetics Showcases New Research and Product
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesSalt lake cityMatt scaloGlenn farrellHollyj pedersonBracanalysis cdxGeorge daneker jrExchange commissionOncology solutionsA myriad collaborative research registry studyCollaborative research registryUniversity of texas md anderson cancer centerNational cancer center hospitalGenetics incBreast servicesMemorial sloan kettering cancer center

Myriad Genetics, Inc (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript

Myriad Genetics, Inc (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSalt lake citySalt lakeSouth san franciscoMatt scaloMatthew scaloDoug schenkelDan brennanPuneet soudaMychoice cdxMark verrattiGeorge danekerSam rahaPaul diazBracanalysis cdx

Myriad Genetics, Inc (NASDAQ:MYGN) Q4 2023 Earnings Call Transcript

Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2023 Earnings Call Transcript February 27, 2024 Myriad Genetics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $0.02. Myriad Genetics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome […]

Salt lake cityUnited statesSam rahaMatt scaloScott lefflerPaul diazGenetics precision oncology solutionsNet promoter scoreMyriad collaborativeMyriad genetics precision oncology solutionsSouth san franciscoSalt lakePrecise tumorPrecise liquid testsSalt lake city westChief financial